IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Remedium Capital Partners, LLC

Q4 2025 Holdings

Filed 2026-02-12 | 6 holdings | $116.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spyre Therapeutics Inc(SYRE)COM00773J202$47.7M1,456,23141.1%
Apogee Therapeutics Inc(APGE)COM03770N101$44.1M583,59137.9%
Jade Biosciences Inc(JBIO)COM008064206$24.3M1,577,75021.0%
Oruka Therapeutics Inc(ORKA)COM687604108$47.1K1,552,4140.0%
Crescent Biopharma IncCOM38000Q201$4.3K361,2500.0%
Galecto Inc(GLTO)COM36322Q206$2.8K120,4730.0%